Clinical Trial Update: DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on Phase 2/Phase 3 evaluating DC-CIK immunotherapy added to chemotherapy versus chemotherapy alone for adjuvant treatment of stage III col…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• DC-CIK immunotherapy (dendritic cell-cytokine-induced killer cell therapy)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Colorectal Cancer | Phase 2, Phase 3 | Status: UNKNOWN